Trial intelligence / Profile preview

Safety and Efficacy of CT Gel in Acne Vulgaris

NCT00689117Phase 3Completed

Sponsor
GSK
Start
Apr 2008
Primary completion
Apr 2009
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of clindamycin, tretinoin in acne vulgaris, sponsored by GSK. Started Apr 2008; status: completed.

02

Drugs

clindamycintretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00689117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00689117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call